Cargando…
Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern
BACKGROUND: Prisoners constitute a high-risk population, particularly for infectious diseases. The aim of this study was to estimate the level of infectious risk in the prisons of five different European countries by measuring to what extent the prison system adheres to WHO/UNODC recommendations. ME...
Autores principales: | Michel, Laurent, Lions, Caroline, Van Malderen, Sara, Schiltz, Julie, Vanderplasschen, Wouter, Holm, Karina, Kolind, Torsten, Nava, Felice, Weltzien, Nadja, Moser, Andrea, Jauffret-Roustide, Marie, Maguet, Olivier, Carrieri, Patrizia M, Brentari, Cinzia, Stöver, Heino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624386/ https://www.ncbi.nlm.nih.gov/pubmed/26507505 http://dx.doi.org/10.1186/s12889-015-2421-y |
Ejemplares similares
-
Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
por: Michel, Laurent, et al.
Publicado: (2011) -
“My first 48 hours out”: drug users’ perspectives on challenges and strategies upon release from prison
por: Jamin, Daniela, et al.
Publicado: (2021) -
Drug use and opioid substitution treatment for prisoners
por: Stöver, Heino, et al.
Publicado: (2010) -
The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases
por: Stöver, Heino, et al.
Publicado: (2021) -
Hepatitis C in European prisons: a call for an evidence-informed response
por: Arain, Amber, et al.
Publicado: (2014)